Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | CA12 | O43570 | 5/20 | 0.46 |
| ▸ | CA1 | P00915 | 5/20 | 0.46 |
| ▸ | CA2 | P00918 | 5/20 | 0.46 |
| ▸ | CA9 | Q16790 | 5/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1866771 | 0.97 | GAA (0.57) | GAACA12CA1CA2CA9 | |
| SCHEMBL1871683 | 0.84 | GAA (0.59) | GAACA12CA1CA2CA9 | |
| SCHEMBL1872067 | 0.82 | ALDH1A1 (0.43) | GAAKMT2AALDH1A1MEN1TP53 | |
| SCHEMBL1868005 | 0.75 | CA12 (0.54) | GAACA12CA1CA2CA9 | |
| SCHEMBL14730616 | 0.75 | ALDH1A1 (0.39) | GAAKMT2AALDH1A1TP53SMN1; SMN2 | |
| SCHEMBL1872209 | 0.74 | CA12 (0.41) | GAACA12CA1CA2CA9 | |
| Hexamethylolmelamine SCHEMBL10631120 | 0.68 | GAA (0.34) | GAAKMT2AALDH1A1MEN1 | |
| Methoxymethane SCHEMBL9721876 | 0.68 | GAA (0.37) | GAACA1CA2CA9ALDH1A1 | |
| SCHEMBL14292534 | 0.68 | GAA (0.39) | GAACA12CA1CA2CA9 | |
| SCHEMBL11704831 | 0.67 | KDM4E (0.60) | GAAKMT2AALDH1A1MEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110105654-A1 | Method for Producing a Compound with at Least One at Least Monosubstituted Amino Group | BOREALIS AGROLINZ MELAMINE GMBH (AT) | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105654-A1 | Method for Producing a Compound with at Least One at Least Monosubstituted Amino Group | GNMT, PAM, SMOX | GAA 1319/4885CA12 190/4885CA1 129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.